Anti-interleukin-23 P19 antibodies and methods of use thereof
US12365727B2 · kind B2 · utility
0Cited by
7References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2022 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Dec 2, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies and antibody fragments thereof that bind to IL-23p19. The disclosed antibodies and antibody fragments thereof can modulate a biological activity of the IL-23 receptor signaling axis and are therefore useful for the treatment of immune-mediated inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.